Stocks News

LAST PRICE
192.4200
TODAY'S CHANGE (%)
Trending Up4.7400 (2.5256%)

Bid / Lots
190.0000/ 2
Ask / Lots
195.5000/ 1
Open / Previous Close
186.6200 / 187.6800
Day Range
Low 186.6200
High 194.5400
52 Week Range
Low 125.8200
High 298.9500
Volume
989,103
above average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

May 30, 2024
- DJ Insulet Initiated at Buy by Redburn Atlantic, from 6:21AM ET on Thursday May 30, 2024 by Dow Jones
  6:21AM ET on Thursday May 30, 2024 by Dow Jones
  Companies Mentioned: PODD
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/PODD/analyst-ratings
  
  (END) Dow Jones Newswires
  
  May 30, 2024 06:21 ET (10:21 GMT)
- Redburn Atlantic Initiates Insulet With Buy Rating, $235 Price Target, from 6:14AM ET on Thursday May 30, 2024 by MT Newswires
  6:14AM ET on Thursday May 30, 2024 by MT Newswires
  Companies Mentioned: PODD
  06:14 AM EDT, 05/30/2024 (MT Newswires) -- Insulet (PODD) has an average rating of outperform and price targets ranging from $185 to $270, according to analysts polled by Capital IQ. (MT Newswires covers equity, commodity and economic research from ...
May 29, 2024
- Insulet Insider Sold Shares Worth $596,970, According to a Recent SEC Filing, from 4:11PM ET on Wednesday May 29, 2024 by MT Newswires
  4:11PM ET on Wednesday May 29, 2024 by MT Newswires
  Companies Mentioned: PODD
  04:11 PM EDT, 05/29/2024 (MT Newswires) -- Timothy J Scannell, Director, on May 28, 2024, sold 3,300 shares in Insulet (PODD) for $596,970. Following the Form 4 filing with the SEC, Scannell has control over a total of 42,586 shares of the company, ...
May 28, 2024
- Insulet to Present at the Jefferies Global Healthcare Conference, from 6:00AM ET on Tuesday May 28, 2024 by Business Wire
  6:00AM ET on Tuesday May 28, 2024 by Business Wire
  Companies Mentioned: PODD
  Insulet Corporation (NASDAQ: PODD) (Insulet), the global leader in tubeless insulin pump technology with its Omnipod(R) brand of products, today announced that management will present at the Jefferies Global Healthcare Conference in New York City on Thursday, June 6, 2024 at 9:00 a.m. (Eastern Time).
- Insulet to Present at the Jefferies Global Healthcare Conference, from 6:00AM ET on Tuesday May 28, 2024 by Dow Jones
  6:00AM ET on Tuesday May 28, 2024 by Dow Jones
  Companies Mentioned: PODD
  ACTON, Mass.--(BUSINESS WIRE)--May 28, 2024--
  Insulet Corporation (NASDAQ: PODD) (Insulet), the global leader in tubeless insulin pump technology with its Omnipod(R) brand of products, today announced that management will present at the Jefferies Global Healthcare Conference in New York City on Thursday, June 6, 2024 at 9:00 a.m. (Eastern Time).

May 30, 2024
- Sector Update: Health Care, from 8:21AM ET on Thursday May 30, 2024 by MT Newswires
  8:21AM ET on Thursday May 30, 2024 by MT Newswires
  Companies Mentioned: SWAV, SRPT
- Sarepta Therapeutics to Replace Shockwave Medical in S&P MidCap 400, from 4:55AM ET on Thursday May 30, 2024 by MT Newswires
  4:55AM ET on Thursday May 30, 2024 by MT Newswires
  Companies Mentioned: JNJ, SWAV, SRPT
May 29, 2024
- Sarepta Therapeutics Set to Join S&P MidCap 400, from 5:49PM ET on Wednesday May 29, 2024 by PR Newswire
  5:49PM ET on Wednesday May 29, 2024 by PR Newswire
  Companies Mentioned: SPGI, SWAV
- BTIG Adjusts Globus Medical's Price Target to $72 From $63, Keeps Buy Rating, from 8:08AM ET on Wednesday May 29, 2024 by MT Newswires
  8:08AM ET on Wednesday May 29, 2024 by MT Newswires
  Companies Mentioned: GMED
May 22, 2024
- Repligen Insider Sold Shares Worth $3,377,283, According to a Recent SEC Filing, from 5:17PM ET on Wednesday May 22, 2024 by MT Newswires
  5:17PM ET on Wednesday May 22, 2024 by MT Newswires
  Companies Mentioned: RGEN
May 20, 2024
- Piper Sandler Upgrades Globus Medical to Overweight From Neutral, Adjusts Price Target to $80 From $60, from 6:59AM ET on Monday May 20, 2024 by MT Newswires
  6:59AM ET on Monday May 20, 2024 by MT Newswires
  Companies Mentioned: GMED
May 16, 2024
- Johnson & Johnson to Buy Proteologix For $850 Million in Cash, from 1:41PM ET on Thursday May 16, 2024 by MT Newswires
  1:41PM ET on Thursday May 16, 2024 by MT Newswires
  Companies Mentioned: JNJ, SWAV
May 14, 2024
- Globus Medical Insider Sold Shares Worth $4,090,022, According to a Recent SEC Filing, from 5:24PM ET on Tuesday May 14, 2024 by MT Newswires
  5:24PM ET on Tuesday May 14, 2024 by MT Newswires
  Companies Mentioned: GMED
May 13, 2024
- Johnson & Johnson Offering Notes to Help Fund Shockwave Medical Acquisition, from 11:01AM ET on Monday May 13, 2024 by MT Newswires
  11:01AM ET on Monday May 13, 2024 by MT Newswires
  Companies Mentioned: JNJ, SWAV
- Morgan Stanley Raises Price Target on Globus Medical to $67 From $57, Keeps Equalweight Rating, from 7:07AM ET on Monday May 13, 2024 by MT Newswires
  7:07AM ET on Monday May 13, 2024 by MT Newswires
  Companies Mentioned: GMED

Insulet Corp
NASDAQ:PODDUnited States

Search Criteria

May 30, 2024

DJ Insulet Initiated at Buy by Redburn Atlantic, from 6:21AM ET on Thursday May 30, 2024 by Dow Jones

Redburn Atlantic Initiates Insulet With Buy Rating, $235 Price Target, from 6:14AM ET on Thursday May 30, 2024 by MT Newswires

May 29, 2024

Insulet Insider Sold Shares Worth $596,970, According to a Recent SEC Filing, from 4:11PM ET on Wednesday May 29, 2024 by MT Newswires

May 28, 2024

Insulet to Present at the Jefferies Global Healthcare Conference, from 6:00AM ET on Tuesday May 28, 2024 by Business Wire

Insulet to Present at the Jefferies Global Healthcare Conference, from 6:00AM ET on Tuesday May 28, 2024 by Dow Jones

Peers Headlines

May 30, 2024

Sector Update: Health Care, from 8:21AM ET on Thursday May 30, 2024 by MT Newswires

Sarepta Therapeutics to Replace Shockwave Medical in S&P MidCap 400, from 4:55AM ET on Thursday May 30, 2024 by MT Newswires

May 29, 2024

Sarepta Therapeutics Set to Join S&P MidCap 400, from 5:49PM ET on Wednesday May 29, 2024 by PR Newswire

BTIG Adjusts Globus Medical's Price Target to $72 From $63, Keeps Buy Rating, from 8:08AM ET on Wednesday May 29, 2024 by MT Newswires

May 22, 2024

Repligen Insider Sold Shares Worth $3,377,283, According to a Recent SEC Filing, from 5:17PM ET on Wednesday May 22, 2024 by MT Newswires

May 20, 2024

Piper Sandler Upgrades Globus Medical to Overweight From Neutral, Adjusts Price Target to $80 From $60, from 6:59AM ET on Monday May 20, 2024 by MT Newswires

May 16, 2024

Johnson & Johnson to Buy Proteologix For $850 Million in Cash, from 1:41PM ET on Thursday May 16, 2024 by MT Newswires

May 14, 2024

Globus Medical Insider Sold Shares Worth $4,090,022, According to a Recent SEC Filing, from 5:24PM ET on Tuesday May 14, 2024 by MT Newswires

May 13, 2024

Johnson & Johnson Offering Notes to Help Fund Shockwave Medical Acquisition, from 11:01AM ET on Monday May 13, 2024 by MT Newswires

Morgan Stanley Raises Price Target on Globus Medical to $67 From $57, Keeps Equalweight Rating, from 7:07AM ET on Monday May 13, 2024 by MT Newswires